J Duval
- Molecular Medicine top 0.5%
- Antibiotic Resistance in Bacteria 45
- Clinical Biochemistry top 0.5%
- Bacterial Identification and Susceptibility Testing 9
- Infectious Diseases top 1%
- Antimicrobial Resistance in Staphylococcus 24
-
- Antibiotic Use and Resistance 19
- Endocrinology top 2%
-
- Antibiotics Pharmacokinetics and Efficacy 38
-
- Streptococcal Infections and Treatments 5
-
- Pneumonia and Respiratory Infections 5
-
- Biochemical and Molecular Research 4
J Duval
77 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 90
- Molecular Medicine 711
- Clinical Biochemistry 594
- Infectious Diseases 1.1k
- Applied Microbiology and Biotechnology 96
- Endocrinology 205
Countries citing papers authored by J Duval
This map shows the geographic impact of J Duval's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Duval with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Duval more than expected).
Fields of papers citing papers by J Duval
This network shows the impact of papers produced by J Duval. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Duval. The network helps show where J Duval may publish in the future.
Co-authorship network
The 25 scholars most cited alongside J Duval, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1996 | 7 | |
| 2 | 1993 | 24 | |
| 3 | 1993 | 105 | |
| 4 | 1992 | 8 | |
| 5 | 1992 | 93 | |
| 6 | 1992 | 26 | |
| 7 | 1989 | 62 | |
| 8 | 1989 | 254 | |
| 9 | [In vitro antibacterial activity of piperacillin/quinolone combinations]. | 1988 | 3 |
| 10 | 1987 | 34 | |
| 11 | [Antibacterial activity in vitro of 10 quinolones against 20 strains of Legionella pneumophila]. | 1986 | 3 |
| 12 | [In vitro activity of a new 3d-generation cephalosporin, cefodizime, on hospital bacteria]. | 1986 | 2 |
| 13 | 1985 | 35 | |
| 14 | [Effect of the amoxicillin-gentamicin combination in the presence of clavulanic acid on 8 strains of amoxicillin-resistant bacteria]. | 1984 | 0 |
| 15 | [Multicenter study of the in vitro antibacterial activity of ceftazidime on gram-negative bacilli]. | 1983 | 1 |
| 16 | [Bacterial septicemia in neutropenia patients]. | 1983 | 5 |
| 17 | 1980 | 18 | |
| 18 | [Septicemias of superinfection in resucitation. Their prevention by restriction of antibiotics]. | 1975 | 1 |
| 19 | 1974 | 2 | |
| 20 | [Antibiotic associations on acting Pseudomonas aeruginosa]. | 1971 | 2 |
About J Duval
J Duval is a scholar working on Applied Microbiology and Biotechnology, Molecular Medicine, Pharmacology, Infectious Diseases and Microbiology, having authored 82 papers that have together received 2.1k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (45 papers), Antibiotics Pharmacokinetics and Efficacy (38 papers), Antimicrobial Resistance in Staphylococcus (24 papers), Antibiotic Use and Resistance (19 papers), Bacterial Identification and Susceptibility Testing (9 papers), Streptococcal Infections and Treatments (5 papers), Pneumonia and Respiratory Infections (5 papers) and Biochemical and Molecular Research (4 papers). The work is most often cited by research in Molecular Medicine (711 citations), Clinical Biochemistry (594 citations), Infectious Diseases (1.1k citations), Applied Microbiology and Biotechnology (96 citations) and Endocrinology (205 citations). J Duval has collaborated with scholars based in France, Germany and Italy. Frequent co-authors include Patrice Courvalin, Roland Leclercq, Jacques Tankovic, Sylvie Dutka‐Malen, E Derlot, Marc Galimand, Bruno Périchon, Pierre Legrand, Yael Costa and Christian Brun‐Buisson. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Journal of Antimicrobial Chemotherapy, Clinical Infectious Diseases, European Journal of Clinical Microbiology & Infectious Diseases and Journal of Clinical Microbiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.